Biotech Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours November 11, 2025
Biotech AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025 November 10, 2025
Biotech Preimplantation Genetic Testing Market worth $1,135.0 million by 2030 with 10.5% CAGR | MarketsandMarkets™ November 9, 2025
Biotech ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut November 8, 2025
Biotech Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade November 6, 2025
Biotech Natural Field will Launch “Ashwagandha White Paper” at FTA Forum in Hangzhou November 5, 2025
Biotech GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’ November 4, 2025
Biotech Zhimeng Biopharma’s investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. November 3, 2025
Biotech StimLabs® Announces New Real-World Study Demonstrating Positive Outcomes Using Relese® in the Treatment of Chronic Wounds November 2, 2025
Search
Biotech
November 11, 2025
November 10, 2025
November 9, 2025
November 8, 2025
November 7, 2025
November 6, 2025
November 5, 2025
November 4, 2025
November 3, 2025
November 2, 2025
